Dr. Lynch is a board-certified and fellowship-trained orthopedic surgeon, as well as a venture capitalist. Prior to joining Histogenics, she founded Advisorthopaedics.
Histogenics lead product line is NeoCart, a personalized cartilage tissue implant.
More Articles on Orthopedics:
Dr. Amanda Shepherd Joins Wake Forest Baptist Health-Lexington Medical Center
Joint Commission Awards PBMC Gold Seal of Approval for Hip, Knee Replacement
Kenmore Mercy Hospital Opens $5.4M Orthopedic Wing
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
